This Article Full Text (PDF) All Versions of this Article: 0269881108092336v1 23/7/759    most recent References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Web of Science (1) Citing Articles via Scopus Google Scholar Articles by Allott, K Articles by Redman, J PubMed PubMed Citation Articles by Allott, K Articles by Redman, J Social Bookmarking                         What's this?

Neuroendocrine and subjective responses to pharmacological challenge with citalopram: a controlled study in male and female ecstasy/MDMA users

School of Psychology, Psychiatry and Psychological Medicine, Monash University, Melbourne, Victoria, Australia kallott{at}unimelb.edu.au

BJ Canny

Department of Physiology, Monash University, Melbourne, Victoria, Australia

JH Broadbear

School of Psychology, Psychiatry and Psychological Medicine, Monash University, Melbourne, Victoria, Australia

NK Stepto

Department of Physiology, Monash University, Melbourne, Victoria, Australia

B Murphy

School of Psychology, Psychiatry and Psychological Medicine, Monash University, Melbourne, Victoria, Australia

J Redman

School of Psychology, Psychiatry and Psychological Medicine, Monash University, Melbourne, Victoria, Australia

Abstract

Despite evidence that ±3,4-methylenedioxymethamphetamine (MDMA; ‘ecstasy’) causes persistent alterations to the serotonergic system of animals, evidence for long-term neurological effects of ecstasy/MDMA in humans remains equivocal. The current study assessed serotonin functioning of nine male and 11 female recreational ecstasy polydrug users by measuring neuroendocrine (prolactin, cortisol) responses to pharmacological challenge with the selective serotonin reuptake inhibitor citalopram, compared with nine male and five female cannabis polydrug users and 11 male and 11 female non-drug using controls. A single-blind, randomised, placebo-controlled design was used. Subjective responses, other substance use, mood, personality traits and demographic variables were measured to control for potentially confounding variables. There were no significant differences between ecstasy polydrug users, cannabis polydrug users and non-drug using controls in neuroendocrine or subjective responses to serotonergic challenge, and there were no sex by drug group interactions. There was no relationship between extent of ecstasy use and neuroendocrine functioning, alone or in combination with potential confounding variables. Subjective responses to the pharmacological challenge (nausea, tremor, dry mouth), novelty seeking and lifetime dose of alcohol were the only variables that contributed to one or more of the neuroendocrine outcome variables. These data do not support the premise that recreational ecstasy/MDMA use results in measurable impairment of serotonergic control of endocrine activity.

Key Words: citalopram • cortisol • ecstasy • MDMA • neuroendocrine • prolactin • serotonin • sex differences • subjective responses

This version was published on September 1, 2009

Journal of Psychopharmacology, Vol. 23, No. 7, 759-774 (2009)
DOI: 10.1177/0269881108092336


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?